Related Experiment Video
Updated: May 25, 2026
07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
Prioritization of future genetics education for general practitioners: a Delphi study
Elisa J F Houwink1, Lidewij Henneman, Myrte Westerneng
1Department of Clinical Genetics, Section of Community Genetics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands. e.houwink@vumc.nl
Summary
General practitioners need better genetics education. Key priorities include recognizing hereditary disease signals, evaluating referrals, and understanding genetic test capabilities for improved patient care.
Area of Science:
- Genetics education in primary care
- General practice and hereditary diseases
Background:
- General practitioners (GPs) face increasing demands to provide genetics services.
- Current primary care genetics education is inadequate and requires innovation.
Purpose of the Study:
- To identify and prioritize essential topics for genetics education tailored to general practice.
- To guide the development of improved genetics training for GPs.
Main Methods:
- A three-round Delphi consensus procedure was employed.
- An expert panel (n=18) including GPs, GP trainers, clinical geneticists, and patient representatives participated.
- Participants rated and ranked educational needs in genetics knowledge, skills, and attitudes.
Main Results:
- Significant agreement was reached on the top 10 genetic education priorities (Kendall's W = P < 0.001).
- The highest-ranked need was recognizing potential hereditary disease signals.
- Other key priorities included evaluating referral indications and understanding genetic test utility.
Conclusions:
- The identified priorities can shape educational modules for GPs.
- Improved GP training in genetics can enhance patient care for hereditary conditions.
- Case-based education is recommended for practical skill development.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...